417 related articles for article (PubMed ID: 21607288)
1. Frequent gene products and molecular pathways altered in prostate cancer- and metastasis-initiating cells and their progenies and novel promising multitargeted therapies.
Mimeault M; Batra SK
Mol Med; 2011; 17(9-10):949-64. PubMed ID: 21607288
[TBL] [Abstract][Full Text] [Related]
2. Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.
Mimeault M; Batra SK
Mol Aspects Med; 2014 Oct; 39():3-32. PubMed ID: 23994756
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells.
Mimeault M; Batra SK
J Cell Mol Med; 2013 Jan; 17(1):30-54. PubMed ID: 23301832
[TBL] [Abstract][Full Text] [Related]
4. Animal models relevant to human prostate carcinogenesis underlining the critical implication of prostatic stem/progenitor cells.
Mimeault M; Batra SK
Biochim Biophys Acta; 2011 Aug; 1816(1):25-37. PubMed ID: 21396984
[TBL] [Abstract][Full Text] [Related]
5. Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies.
Mimeault M; Batra SK
Pharmacol Rev; 2010 Sep; 62(3):497-524. PubMed ID: 20716670
[TBL] [Abstract][Full Text] [Related]
6. New advances on critical implications of tumor- and metastasis-initiating cells in cancer progression, treatment resistance and disease recurrence.
Mimeault M; Batra SK
Histol Histopathol; 2010 Aug; 25(8):1057-73. PubMed ID: 20552555
[TBL] [Abstract][Full Text] [Related]
7. Pathobiological implications of the expression of EGFR, pAkt, NF-κB and MIC-1 in prostate cancer stem cells and their progenies.
Mimeault M; Johansson SL; Batra SK
PLoS One; 2012; 7(2):e31919. PubMed ID: 22384099
[TBL] [Abstract][Full Text] [Related]
8. AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer.
Zhu WB; Zhao ZF; Zhou X
J Cell Physiol; 2019 Jul; 234(7):11746-11759. PubMed ID: 30537000
[TBL] [Abstract][Full Text] [Related]
9. Functions of normal and malignant prostatic stem/progenitor cells in tissue regeneration and cancer progression and novel targeting therapies.
Mimeault M; Mehta PP; Hauke R; Batra SK
Endocr Rev; 2008 Apr; 29(2):234-52. PubMed ID: 18292464
[TBL] [Abstract][Full Text] [Related]
10. The ETS factor ESE3/EHF represses IL-6 preventing STAT3 activation and expansion of the prostate cancer stem-like compartment.
Albino D; Civenni G; Rossi S; Mitra A; Catapano CV; Carbone GM
Oncotarget; 2016 Nov; 7(47):76756-76768. PubMed ID: 27732936
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer.
Marín-Aguilera M; Codony-Servat J; Reig Ò; Lozano JJ; Fernández PL; Pereira MV; Jiménez N; Donovan M; Puig P; Mengual L; Bermudo R; Font A; Gallardo E; Ribal MJ; Alcaraz A; Gascón P; Mellado B
Mol Cancer Ther; 2014 May; 13(5):1270-84. PubMed ID: 24659820
[TBL] [Abstract][Full Text] [Related]
12. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X
Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770
[TBL] [Abstract][Full Text] [Related]
13. Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer.
Mimeault M; Batra SK
Gut; 2008 Oct; 57(10):1456-68. PubMed ID: 18791122
[TBL] [Abstract][Full Text] [Related]
14. Novel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomas.
Mimeault M; Batra SK
World J Clin Oncol; 2012 Mar; 3(3):32-42. PubMed ID: 22442756
[TBL] [Abstract][Full Text] [Related]
15. Activation of Notch pathway is linked with epithelial-mesenchymal transition in prostate cancer cells.
Zhang L; Sha J; Yang G; Huang X; Bo J; Huang Y
Cell Cycle; 2017 May; 16(10):999-1007. PubMed ID: 28388267
[TBL] [Abstract][Full Text] [Related]
16. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
17. microRNAs and Prostate Cancer.
Josson S; Chung LW; Gururajan M
Adv Exp Med Biol; 2015; 889():105-18. PubMed ID: 26658999
[TBL] [Abstract][Full Text] [Related]
18. Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1.
Mimeault M; Johansson SL; Batra SK
Br J Cancer; 2013 Mar; 108(5):1079-91. PubMed ID: 23449353
[TBL] [Abstract][Full Text] [Related]
19. Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics.
Dang H; Ding W; Emerson D; Rountree CB
BMC Cancer; 2011 Sep; 11():396. PubMed ID: 21929801
[TBL] [Abstract][Full Text] [Related]
20. Interplay of distinct growth factors during epithelial mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies.
Mimeault M; Batra SK
Ann Oncol; 2007 Oct; 18(10):1605-19. PubMed ID: 17355951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]